STAT+: Will Makary’s FDA voucher program survive?

RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news
Source
Stat News
Opens original article in a new tab

(MedPage Today) -- In this MedPage Today webinar, Editor-in-Chief Jeremy Faust, MD, speaks with Jeremy Konyndyk, president of Refugees International and former U.S. Agency for International Development (USAID) official who helped lead the U.S...

(MedPage Today) -- The following is a transcript of the podcast episode: Rachael Robertson: Hey everyone, welcome to MedPod Today, the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories...

Outbreak response is difficult enough without asking responders to wonder whether they will have access to the best available care if they become ill.

(MedPage Today) -- Note that some links may require registration or subscription. FDA said a multi-year Listeria monocytogenes outbreak linked to soft ricotta/requeson cheese sold in Maryland, New York, and Virginia has hospitalized seven people...